Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
68,671
+5,239
+8% +$112K 0.04% 503
2025
Q4
$1.63M Buy
63,432
+4,652
+8% +$107K 0.06% 331
2025
Q3
$1.26M Buy
58,780
+12,083
+26% +$275K 0.05% 361
2025
Q2
$1.03M Sell
46,697
-14,659
-24% -$322K 0.05% 429
2025
Q1
$1.37M Sell
61,356
-14,159
-19% -$305K 0.08% 230
2024
Q4
$1.3M Buy
75,515
+29,124
+63% +$452K 0.09% 198
2024
Q3
$778K Buy
46,391
+11,488
+33% +$276K 0.05% 365
2024
Q2
$999K Buy
34,903
+8,656
+33% +$261K 0.07% 240
2024
Q1
$1M Buy
26,247
+13,309
+103% +$503K 0.07% 259
2023
Q4
$481K Buy
12,938
+793
+7% +$26.6K 0.04% 335
2023
Q3
$413K Sell
12,145
-330
-3% -$12.5K 0.03% 338
2023
Q2
$491K Buy
+12,475
New +$450K 0.04% 327

Other funds holding PGNY

Winton Group's PGNY Position: Q1 2026 in Review

Winton Group increased its Progyny (PGNY) stake by 8.3% in Q1 2026, buying an estimated $112K and bringing the position to 68,671 shares worth $1.17M. The position accounts for 0.04% of the portfolio, ranked #503.

Winton Group first reported a position in PGNY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.63M in Q4 2025. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Winton Group held 68,671 shares of Progyny worth $1.17M as of Q1 2026.
  • Winton Group bought 5,239 Progyny shares in Q1 2026, an estimated $112K.
  • Progyny made up 0.04% of Winton Group's portfolio in Q1 2026, its #503 holding.
  • Winton Group first reported a position in Progyny in Q2 2023 and has held it in 12 quarters since.
  • Winton Group's Progyny position peaked at $1.63M in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.